Interventional radiologists take lead on reducing disability from dangerous blood clots
CHICAGO, Ill. (March 28, 2011)?Deep vein thrombosis, or DVT: it's more than just a one-time complication from taking a long plane ride. The Society of Interventional Radiology wants individuals to know the risk factors for this very serious condition, which can lead to post-thrombotic syndrome, pulmonary embolism, permanent damage to the leg and even death.
"Individuals and their doctors need to be aware that in the United States alone about 600,000 people are hospitalized with deep vein thrombosis each year and more than 100,000 people die of resulting pulmonary embolism," explained Suresh Vedantham, M.D., FSIR, an interventional radiologist and professor of radiology and surgery at Washington University School of Medicine in St. Louis, Mo. "March is DVT Awareness Month, and there is a need to alert people that deep vein thrombosis?sometimes called Economy Class Syndrome?is not just a one-time complication from taking a long plane ride. It affects men, women and the elderly?even children?whether or not they travel," stressed Vedantham at SIR's 36th Annual Scientific Meeting in Chicago, Ill. He also noted that common risk factors for DVT include prolonged immobility, recent surgery or major injury, hormone therapy or use of birth control pills, current or recent pregnancy, cancer and obesity. The most serious complication of DVT is when a blood clot breaks off and travels to the lung where it can become trapped, blocking the oxygen supply, causing heart failure. This is known as a pulmonary embolism, which can be fatal, said Vedantham. Tennis star Serena Williams recently suffered a pulmonary embolism after being treated for an injury and becoming inactive. "This is frightening proof," said Vedantham, "that these conditions can occur without warning. Early recognition and treatment are essential for survival"
"It is also important for people to know that under-recognized and extremely serious complications, such as post-thrombotic syndrome (or PTS), often occur even when DVT is treated with blood-thinning drugs (or anticoagulation)," said Vedantham. "Blood-thinning drugs are an important part of the treatment; however, contrary to popular belief, they do not actively dissolve the clot; they just prevent new clots from forming. Unfortunately, the clotted vein often suffers permanent damage and a loss of function, which results in long-term disability for the individual," explained Vedantham.
"This is a disease that needs to be thought of as a chronic condition," he said. "And by undertaking pivotal research and working with other physicians to increase awareness," commented Vedantham, "interventional radiologists appear likely to transform the treatment of deep vein thrombosis and its two main complications pulmonary embolism and post-thrombotic syndrome or PTS."
"Studies show that people who have an episode of DVT are at significant risk for developing more blood-clotting episodes and post-thrombotic syndrome, which causes chronic leg pain, swelling, fatigue, difficulty walking, and major interference with physical activity and a person's ability to work productively," said Vedantham. Post-thrombotic syndrome occurs because the clot remains in the leg.
"While the impact of post-thrombotic syndrome has largely been viewed in relation to working-age adults, prospective studies have shown that children with deep vein thrombosis are also at significant risk for the development of post-thrombotic syndrome and its related disabilities," Vedantham reported. "Interventional radiologists, in partnership with medical thrombosis physicians, recently evaluated image-guided clot-busting treatments for the treatment of adolescents with severe DVT," noted Vedantham, who reported, "Their study noted that adolescents with DVT who were treated with clot-removal therapy experienced a very low frequency of post-thrombotic syndrome."
Vedantham also pointed out that the study of clot-removal treatments was listed as a top research priority in the national "Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism" that was issued by former Acting U.S. Surgeon General Steven K. Galson in September 2008. "There are new techniques where clot-busting drugs are infused directly into the clot under imaging guidance through a catheter-device that quickly distributes the drug within the clot using a pulsing fluid spray or a curved wire," Vedantham explained. "The clot then dissolves, sometimes with the help of a device that vacuums it out of the vein, restoring normal blood flow and resolving symptoms," he said. These minimally invasive treatments have worked on even the largest blood clots, said Vedantham who also stated, "These treatments could completely change the way DVT patients are routinely treated."
Recognizing this potential, the National Institutes of Health is sponsoring the Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (ATTRACT) study, a $10 million, multicenter randomized trial that is being performed in 50 hospitals nationwide. Vedantham, its lead investigator indicated, "ATTRACT will address the public health threat of post-thrombotic syndrome by determining if image-guided clot-busting treatments pioneered by interventional radiologists can safely prevent PTS and improve long-term quality of life in patients with a blood clot in the leg." The interventional radiology community, and particularly the SIR Foundation, helped to develop and continues to strongly support this landmark study, which is midway through its patient enrollment period," noted Vedantham.
Additionally, a new study from Washington University in St. Louis found that DVT patients with already established post-thrombotic syndrome that is causing severe long-term leg pain, swelling or skin ulceration can be successfully treated with image-guided treatments that re-open the blocked veins and eliminate backward flow in the veins (known as reflux) that results from valve damage. According to Vedantham, the study's lead investigator, "Significant symptom improvement was observed in 80 percent of patients who were treated with a combination of stents (tiny mesh tubes that re-open blocked veins) and endovenous laser ablation (in which a laser catheter is used to heat the inside of refluxing veins and seal them closed)."
"Because established post-thrombotic syndrome has had no consistently effective treatments, affected patients are generally told that they have to just live with their symptoms, which are often very severe or even disabling," said Vedantham. "Previous and ongoing research provides hope that a strategy of image-guided treatment may alleviate their symptoms, restore their leg function and improve their overall quality of life," he added.